Back to IDXX

IDEXX LABORATORIES INC /DE Accrued Liabilities 2009-2026 | IDXX

Beta

What is accrued liabilities?

Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.

What is IDEXX LABORATORIES INC /DE's current accrued liabilities?

IDEXX LABORATORIES INC /DE (IDXX) annual accrued liabilities for 2025 was $530.1M, a 5.58% increase from 2024. IDEXX LABORATORIES INC /DE accrued liabilities for the quarter ending March 31, 2026 was $453.6M.

What was IDEXX LABORATORIES INC /DE's accrued liabilities in 2024?

IDEXX LABORATORIES INC /DE annual accrued liabilities for 2024 was $502.1M, a 4.89% increase from 2023.

What was IDEXX LABORATORIES INC /DE's accrued liabilities in 2023?

IDEXX LABORATORIES INC /DE annual accrued liabilities for 2023 was $478.7M, a 10.39% increase from 2022.

What is IDEXX LABORATORIES INC /DE's 5-year accrued liabilities CAGR?

IDEXX LABORATORIES INC /DE accrued liabilities grew at a compound annual growth rate (CAGR) of 4.99% from FY2020 to FY2025, going from $415.6M to $530.1M over 5 years.

Accrued Liabilities History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+5.0%
FY2020
$415.6M
FY2025
$530.1M
0910111213141516171819202122232425
5 years selected
Accrued Liabilities History
PeriodValueChangeSource
FY2025$530.1M+5.6%10-K
FY2024$502.1M+4.9%10-K
FY2023$478.7M+10.4%10-K
FY2022$433.7M-5.5%10-K
FY2021$458.9M+10.4%10-K
FY2020$415.6M+28.7%10-K
FY2019$322.9M+23.9%10-K
FY2018$260.7M+2.9%10-K
FY2017$253.4M+7.3%10-K
FY2016$236.1M+14.9%10-K
FY2015$205.5M+5.2%10-K
FY2014$195.4M+31.2%10-K
FY2013$148.9M+8.1%10-K
FY2012$137.7M-2.6%10-K
FY2011$141.4M+19.2%10-K
FY2010$118.6M+13.0%10-K
FY2009$105.0M-10-K
Company: IDEXX LABORATORIES INC /DETicker: IDXXSector: OtherIndustry: In Vitro & In Vivo Diagnostic SubstancesView company profile →